dc.contributor.author
Lange, Kristin Sophie
dc.contributor.author
Forster, Ophélie
dc.contributor.author
Mawet, Jérôme
dc.contributor.author
Tuloup, Gabrielle
dc.contributor.author
Burcin, Cécilia
dc.contributor.author
Corti, Lucas
dc.contributor.author
Duflos, Claire
dc.contributor.author
Roos, Caroline
dc.contributor.author
Ducros, Anne
dc.date.accessioned
2022-11-25T12:11:18Z
dc.date.available
2022-11-25T12:11:18Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/37021
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-36735
dc.description.abstract
Background: In a recent Italian study, 30% of patients with reversible cerebral vasoconstriction syndrome (RCVS) presented without thunderclap headache (TCH), and tended to present more severe forms of RCVS than patients with TCH. We aimed to analyze the risk for complications of RCVS in patients with and without TCH at onset.
Methods: In a pooled cohort of 345 French patients with RCVS, we compared patients with and without TCH at onset regarding rates of neurological complications, and the functional outcome at 3 months.
Results: As compared to the 281 patients with TCH at onset, the 64 patients without TCH had a higher risk for any neurological complication (61% vs. 24%, OR 4.9, 95% CI 2.8-8.7, p < 0.001). The association was strongest for cervical artery dissections (28% vs. 5%, OR 8.1, 95% CI 3.7-17.6, p < 0.001), followed by posterior reversible encephalopathy syndrome (17% vs. 3%, OR 7.1, 95% CI 2.7-18.4, p < 0.001), seizures (9% vs. 2.5%, OR 4.1, 95% CI 1.3-12.5, p = 0.019), and subarachnoid hemorrhage (41% vs. 16%, OR 3.5, 95% CI 1.9-6.3, p < 0.001). In multivariable analysis, the risk for any neurological complication remained significantly elevated in the absence of TCH (OR 3.5, 95% CI 1.8-6.8, p < 0.001). The functional outcome was equal in both groups, with a modified Rankin scale score of 0-1 in ≥90% of patients.
Conclusions: Absence of TCH at onset might predict a higher risk of complications in RCVS. Our results warrant further multicentric studies to prove this finding.
en
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject
calcitonin gene-related peptide
en
dc.subject
cerebrovascular diseases
en
dc.subject
reversible cerebral vasoconstriction syndrome
en
dc.subject
thunderclap headache
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Type of headache at onset and risk for complications in reversible cerebral vasoconstriction syndrome
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1111/ene.15064
dcterms.bibliographicCitation.journaltitle
European Journal of Neurology
dcterms.bibliographicCitation.number
1
dcterms.bibliographicCitation.originalpublishername
Wiley
dcterms.bibliographicCitation.pagestart
130
dcterms.bibliographicCitation.pageend
137
dcterms.bibliographicCitation.volume
29
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
DEAL Wiley
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
34390103
dcterms.isPartOf.issn
1351-5101
dcterms.isPartOf.eissn
1468-1331